Mr. Tomasz Zieliński | Organic Chemistry | Innovative Research Award

Posted on by Chemistry Awards

Mr. Tomasz Zieliński | Organic Chemistry | Innovative Research Award

Mr. Tomasz Zieliński , Organic Chemistry, Nicolaus Copernicus University in Toruń , Poland

Tomasz Zielińsk , is an experienced chemical technologist with over 16 years in the refining and petrochemical industries. Working primarily at ORLEN S.A. in Płock, he’s contributed extensively to production technology, process optimization, and innovative projects enhancing refinery capacities by up to 40%. As an expert in alternative fuels and sustainable technologies, Tomasz serves on several national groups dealing with alternative fuels, climate regulations, and product quality. He’s currently pursuing a Ph.D. at Nicolaus Copernicus University in Toruń, focusing on innovative processes like microbiological hydrocarbon decomposition. With patented technology to produce valuable compounds like isopropanol and hydrogen, he envisions expanding synthetic fuel production to meet EU directives like RED III and Fit for 55. Known for analytical skills, innovative thinking, and leadership in project execution, Tomasz is a key figure driving technological transformation in Poland’s energy sector.

Professional Profile : 

Orcid 

Summary of Suitability for Award:

Developed a patented microbiological process for decomposing hydrocarbon residues into valuable compounds like isopropanol and hydrogen. Proposed using this technology to boost synthetic fuel production and hydrogen integration, contributing to EU climate goals. Successfully resolved critical fuel quality issues (Jet A-1, diesel), safeguarding production reliability and market reputation. Led projects implementing new fuel formulations (e.g. Efecta fuels), demonstrating practical innovation. Strong analytical skills, innovation mindset, project management, and cross-disciplinary collaboration. Demonstrated ability to translate complex research into real-world applications. Tomasz Zieliński’s track record of technological innovations, impactful problem-solving, and visionary research directions positions him as a very strong candidate for the “Innovative Research Award”. His unique blend of industrial experience, scientific research, and successful technology implementations aligns perfectly with the award’s purpose of recognizing groundbreaking contributions that advance industry and sustainability. His work has the potential to contribute significantly to cleaner fuels, process efficiency, and Europe’s climate goals, underscoring his innovative spirit and leadership in his field.

🎓Education:

Tomasz Zieliński’s educational path reflects his dedication to chemical technology and industrial safety. He began at the Zespół Szkół Centrum Edukacji in Płock, where he qualified as a Technician in Chemical Technology (2002-2006). He then earned his Bachelor’s degree in Chemical Technology (specializing in organic technology) at the Warsaw University of Technology (2006-2010). Continuing at the same university, he completed his Master of Engineering in Chemical Technology in 2012. Recognizing the importance of workplace safety, he pursued postgraduate studies in Occupational Health and Safety at the Cracow University of Technology in 2012-2013. Currently, he’s working toward a Ph.D. at Nicolaus Copernicus University in Toruń, diving deeper into innovative chemical processes and technologies. His diverse education equips him with technical expertise, research capabilities, and a keen understanding of industrial standards, crucial for leading advanced projects in the petrochemical sector.

🏢Work Experience:

Over 16 years, Tomasz Zieliński has built a robust career at ORLEN S.A., gaining hands-on and strategic experience. From 2004-2009, he undertook practical training on various installations like Catalytic Cracking, Olefins II, and butadiene production. Between 2009 and 2014, he worked as a Senior Process Operator on the Claus installation. From 2015 to mid-2023, he held the position of Senior Specialist in the Technology Office, tackling complex issues like diesel fuel stability and Jet A-1 fuel quality. Since July 2023, he’s been an Expert in the Project Coordination Team, overseeing efficiency, development, and revitalization projects. Notable achievements include resolving quality problems in fuels, leading technological trials for HVO blending, and coordinating large-scale innovation projects. His experience spans process optimization, analytical testing, project management, and implementation of new technologies, making him an essential contributor to refining and petrochemical advancements.

🏅Awards: 

Although specific official awards weren’t detailed in the CV text, Tomasz Zieliński’s professional record showcases significant achievements and recognition within ORLEN S.A. and the broader industry. His contributions have been acknowledged through leadership roles in critical projects, particularly resolving quality challenges in diesel and jet fuels and pioneering new fuel blends like Efecta. His patented technology for microbiological decomposition of residual hydrocarbons underscores his innovative drive and commitment to sustainability. Participation in national groups under POPIHN (Polish Organization of Oil Industry and Trade) reflects peer recognition of his expertise in alternative fuels, climate policy, and regulatory matters. His ongoing Ph.D. research also highlights academic pursuit and potential future honors. Tomasz’s career is marked by trust and respect from colleagues and industry leaders, testifying to his reputation as a talented, forward-thinking professional dedicated to technological progress and environmental responsibility.

🔬Research Focus:

Tomasz Zieliński’s research centers on sustainable energy and petrochemical innovation. His current Ph.D. work at Nicolaus Copernicus University explores microbiological decomposition of residual hydrocarbons, leading to production of isopropanol and hydrogen — crucial raw materials for petrochemical processes and synthetic fuels. His focus aligns with EU sustainability goals like RED III and Fit for 55, aiming to decarbonize fuel production and optimize refinery operations. Beyond his academic pursuits, Tomasz engages in practical projects, such as integrating hydrogen and synthetic fuel production into ORLEN’s infrastructure, utilizing innovative methods to maximize plant capacities. He’s deeply involved in evaluating fuel quality, blending biocomponents like HVO with diesel, and advancing new fuel formulations. His work bridges industrial application and scientific research, demonstrating how innovative technologies can drive energy transformation and secure Poland’s position in the evolving global energy market.

Publication Top Notes:

🧪 Synthesis of Silver Nanoparticles by Chemical Vapor Deposition Method and Its Application in Laser Desorption/Ionization Techniques

 

Assist. Prof. Dr. Changtong YANG | Medicinal Chemistry | Best Researcher Award

Posted on by Chemistry Awards

Assist. Prof. Dr. Changtong YANG | Medicinal Chemistry | Best Researcher Award

Assist. Prof. Dr. Changtong YANG , Medicinal Chemistry,  Radiochemist/Chemist at Singapore General Hospital, Singapore

Dr. Chang-Tong Yang is a renowned radiochemist based in Singapore, specializing in radiopharmaceuticals and molecular imaging. He currently serves as an Assistant Professor in the Radiological Science Academic Clinical Programme at Duke-NUS Medical School and as a Radiochemist at Singapore General Hospital. With over two decades of experience, Dr. Yang has made significant contributions to the development of nuclear imaging probes and radiolabeled therapeutics. His research career spans prestigious institutions, including Nanyang Technological University and A*STAR. Dr. Yang is internationally recognized for advancing nanomaterial probes and novel radiolabeling strategies. He has authored impactful publications in top-tier journals, reflecting his innovation in theranostics, radiochemistry, and nanomedicine. With a strong background in academic and clinical research, Dr. Yang continues to shape the future of molecular imaging for personalized medicine. His global education and interdisciplinary expertise make him a leading figure in translational radiochemistry research.

Professional Profile : 

Orcid

Scopus 

Summary of Suitability for Award:

Dr. Chang-Tong Yang exemplifies the qualities of a “Best Researcher Award” recipient. His innovative contributions to radiochemistry and molecular imaging, combined with a strong publication record, interdisciplinary leadership, and global training, establish him as a trailblazer in translational medical research. His work is not only scientifically rigorous but also clinically impactful, directly advancing the field of nuclear medicine. Therefore, he is highly recommended for recognition as a top-tier researcher deserving of this award.

🎓Education:

Dr. Chang-Tong Yang received his Ph.D. in Chemistry from the National University of Singapore (1998–2002), where he laid the foundation for his career in radiochemistry. He further enhanced his expertise with postdoctoral fellowships at three prestigious U.S. institutions: University of Iowa (2003–2005), University of Michigan (2005–2006), and Purdue University (2006–2007), focusing on chemistry and health sciences. These formative years provided Dr. Yang with a multidisciplinary perspective in synthetic chemistry, radiopharmaceutical development, and imaging sciences. His international training exposed him to cutting-edge methodologies and collaborative projects across biomedical research, which he has since translated into innovative imaging solutions. The combination of rigorous education and hands-on research across these top institutions shaped his ability to bridge fundamental science with clinical applications, particularly in nuclear medicine and molecular imaging.

🏢Work Experience:

Dr. Chang-Tong Yang brings extensive professional experience across both academic and clinical research settings. He is currently an Assistant Professor at Duke-NUS Medical School (2020–present) under the Radiological Science ACP, focusing on radiopharmaceutical sciences. Concurrently, he serves as a Radiochemist at Singapore General Hospital (2018–present) in the Department of Nuclear Medicine & Molecular Imaging, where he translates research into clinical practice. Prior to that, he worked as a Senior Scientist at Nanyang Technological University (2014–2018), contributing to molecular imaging initiatives within the Lee Kong Chian School of Medicine. He also held a Senior Scientist role at A*STAR’s Singapore Bio-Imaging Consortium (2007–2014), leading various radiochemistry research programs. Across these roles, Dr. Yang has developed and validated imaging agents, optimized radiolabeling techniques, and led translational studies that impact diagnostic imaging and therapeutic strategies. His multidisciplinary engagements underscore his pivotal role in bridging chemistry and medicine.

🏅Awards: 

While specific awards are not listed in the available data, Dr. Chang-Tong Yang’s extensive contributions to radiopharmaceuticals and molecular imaging reflect a highly respected and impactful career. His appointments at top institutions such as Duke-NUS, A*STAR, and Singapore General Hospital indicate peer recognition and institutional trust. His publications in reputed journals such as Molecules, Nanomaterials, and Drug Discovery Today highlight his standing in the scientific community. His ongoing leadership roles and collaboration with clinicians further underscore professional acknowledgment of his expertise. Dr. Yang’s selection for multiple postdoctoral positions at prestigious U.S. institutions—University of Iowa, University of Michigan, and Purdue University—suggests early recognition of his academic promise. His interdisciplinary contributions to nuclear medicine, nanotechnology, and molecular imaging may have earned him internal institutional awards, research grants, and invitations to present at scientific forums, which commonly accompany such roles.

🔬Research Focus:

Dr. Chang-Tong Yang’s research is centered on radiopharmaceutical science, with a strong emphasis on the development of molecular imaging probes and radiolabeled nanomaterials for diagnostic and therapeutic applications. His expertise lies in designing novel radioisotope-labeled compounds for use in nuclear medicine imaging techniques such as PET and SPECT, targeting cancer and other pathological conditions. He is particularly interested in enhancing the in vivo behavior of nanomaterial-based agents, improving tumor targeting, retention, and safety. Dr. Yang also explores the biocompatibility and stability of these probes, including how formulation and labeling protocols influence their function. His translational work bridges laboratory innovations with clinical imaging requirements, enabling personalized diagnostics and theranostic approaches. Furthermore, he investigates radiochemical compatibility in clinical settings, such as the mixing of imaging agents with contrast media, which supports safe and effective imaging protocols. His work integrates chemistry, imaging, and clinical practice seamlessly.

Publication Top Notes:

1. pH-Induced In Situ Aggregation of Cu₂₋ₓSe-POED with Extended Tumor Retention for Enhanced Chemodynamic/Photothermal Therapy

2. Standard Radio-Iodine Labeling Protocols Impaired the Functional Integrity of Mesenchymal Stem/Stromal Cell Exosomes

3. Radiolabeled Liposomes for Nuclear Imaging Probes

4. Radiochemical Feasibility of Mixing of 99mTc-MAA and 90Y-Microspheres with Omnipaque Contrast

5. Nanomaterial Probes for Nuclear Imaging

6. Positron Emission Tomographic Imaging in Drug Discovery

7. An In Vivo Study of a Rat Fluid-Percussion-Induced Traumatic Brain Injury Model with [11C]PBR28 and [18F]flumazenil PET Imaging

8. Gadolinium-Based Bimodal Probes to Enhance T1-Weighted Magnetic Resonance/Optical Imaging

9. Activatable Cell-Penetrating Peptide Conjugated Polymeric Nanoparticles with Gd-Chelation and Aggregation-Induced Emission for Bimodal MR and Fluorescence Imaging of Tumors

10. Dealing with PET Radiometabolites

11. PET-MR and SPECT-MR Multimodality Probes

 

Dr. Lemlem Gebremariam Aregawi | Medicinal Chemistry | Best Researcher Award

Posted on by Chemistry Awards

Dr. Lemlem Gebremariam Aregawi | Medicinal Chemistry | Best Researcher Award

Dr. Lemlem Gebremariam Aregawi , Medicinal Chemistry , PhD Candidate at University of Debrecen, Hungary

Lemlem Gebremariam Aregawi is an Ethiopian health professional and researcher currently pursuing a Ph.D. in Nutritional Sciences at the University of Debrecen, Hungary. With over a decade of academic and clinical experience, she has made significant contributions to public health, particularly in the areas of reproductive health, clinical nutrition, and functional gastrointestinal disorders. She served in academic, research, and leadership roles at Adigrat University and Mekelle University in Ethiopia before moving to Hungary on a prestigious scholarship. Her current research explores the therapeutic potential of natural compounds like ginger, and she has presented at numerous international scientific conferences. Lemlem is a published author with more than 19 scientific papers in peer-reviewed journals, and several are currently under review. She has also served as an external examiner for multiple universities. Her multidisciplinary expertise bridges laboratory science, clinical practice, and public health interventions with a strong focus on evidence-based approaches.

Professional Profile :         

Orcid 

Summary of Suitability for Award:

Dr. Lemlem Gebremariam Aregawi is an accomplished Ethiopian researcher in Nutritional Sciences, currently pursuing her Ph.D. at the University of Debrecen, Hungary. Her dedication to advancing clinical nutritional research, particularly involving ginger supplementation and gastrointestinal health, has resulted in over 19 peer-reviewed publications, with multiple clinical trials and systematic reviews in high-impact journals such as Current Therapeutic Research, Advances in Integrative Medicine, and Clinical Nutrition Open Science. Her work is pioneering in its translational focus on using natural compounds to improve public health outcomes. Given her extensive research output, commitment to evidence-based public health interventions, and international academic footprint, Dr. Lemlem Gebremariam Aregawi is a highly suitable candidate for the “Best Researcher Award”. Her work exemplifies the integration of scientific rigor, clinical relevance, and community health impact—making her an outstanding researcher deserving of global recognition.

🎓Education:

Lemlem Gebremariam Aregawi is a Ph.D. candidate in Nutritional Sciences at the University of Debrecen, Hungary (2019–present), where she is conducting clinical trial-based research focusing on dietary interventions and gastrointestinal health. She earned her Master of Public Health in Reproductive Health from Mekelle University, Ethiopia (2011–2013), gaining deep insights into maternal and child health and community-based healthcare strategies. Prior to that, she completed her Bachelor of Science in Medical Laboratory Technology at Jimma University, Ethiopia (2004–2006), where she developed solid clinical and laboratory diagnostic skills. Her academic journey is enriched with various specialized trainings from institutions such as Virge University in the Netherlands, and multiple pedagogical certifications from programs sponsored by USAID and the Ethiopian Ministry of Education. Her education reflects a rich integration of scientific research, health promotion, laboratory diagnostics, and public health practice—laying a strong foundation for her ongoing research and academic pursuits in nutritional science.

🏢Work Experience:

Lemlem Gebremariam Aregawi has accumulated diverse experience in academia, healthcare, and research over nearly two decades. Since 2019, she has been a Ph.D. researcher at the University of Debrecen, Hungary, working on clinical trials evaluating the nutritional effects of ginger. Prior to this, she served as Assistant Professor and Head of Research and Community Services at Adigrat University, Ethiopia (2014–2019), where she also taught public health and coordinated community programs. She worked briefly as a Clinical Laboratory Expert at Ayder Comprehensive Specialized Hospital, Mekelle University (2013–2014), and previously as Assistant Lecturer and Department Head at Mekelle Health Sciences College (2007–2011). Her early career began as a Medical Laboratory Technologist at Axum St. Merry Hospital (2006–2007). She has also served as an external examiner at Mekelle and Axum Universities. Lemlem’s roles span education, laboratory diagnostics, health systems strengthening, and nutritional research, reflecting her multidisciplinary expertise and leadership.

🏅Awards: 

Lemlem Gebremariam Aregawi has been recognized for her academic excellence, leadership, and commitment to public health. She is a recipient of a competitive international scholarship to pursue her Ph.D. studies in Hungary, highlighting her research potential and academic distinction. Throughout her career in Ethiopia, she earned accolades for her outstanding contributions as Head of Research and Community Services at Adigrat University. Lemlem has also been selected as an external examiner for both undergraduate and postgraduate students, reflecting her academic credibility and peer recognition. She has completed prestigious international training, including a pre-doctoral program at Virge University, Amsterdam. Additionally, she received multiple certifications from USAID-sponsored initiatives and Ethiopia’s Ministry of Education, including Training of Trainers (ToT) certifications on sexual and reproductive health, curriculum development, and biosafety. These honors and professional development achievements underscore her commitment to quality education, public health, and global scientific collaboration.

🔬Research Focus:

Lemlem Gebremariam Aregawi’s research centers on the role of nutritional interventions—particularly ginger—in preventing and managing chronic gastrointestinal conditions and metabolic disorders. As a Ph.D. candidate, she is currently engaged in clinical trials investigating the efficacy, safety, and quality-of-life impacts of ginger supplementation in patients with functional dyspepsia. Her broader interests include the therapeutic role of bioactive compounds in disease prevention, integrative medicine, reproductive health, and public health nutrition. She has authored several systematic reviews on ginger’s pharmacological effects, including its impact on body weight, gastrointestinal malignancies, diabetes mellitus, and inflammatory bowel disease. Lemlem’s work bridges clinical nutrition, public health, and biomedical sciences, offering evidence-based insights into the dietary management of chronic diseases. Her multidisciplinary approach enables her to evaluate both biological mechanisms and public health implications of nutritional therapies, with the ultimate goal of translating scientific findings into practical dietary recommendations and health policies.

Publication Top Notes:

“Ginger’s Nutritional Implication on Gastrointestinal Health”

“Evaluation of Adverse Effects and Tolerability of Dietary Ginger Supplementation in Patients with Functional Dyspepsia”

“Effects of Ginger Supplementation on Quality of Life in Patients with Functional Dyspepsia: An Open-Label, Clinical Trial”

“Preventive and Therapeutic Effects of Ginger on Bowel Disease: A Review of Clinical Trials”

“The Effect of Ginger Supplementation on the Improvement of Dyspeptic Symptoms in Patients With Functional Dyspepsia”

“Ginger Constituents and Its Effects on Gastrointestinal Malignancies: A Review of Clinical Trials”

“Assessment of Service Satisfaction and Associated Status Among Women Who Have Given Birth in Adigrat General Hospital, Ethiopia”

“Prevalence and Determinants of Modern Contraceptive Utilization Among Women in the Reproductive Age Group in Edaga-Hamus Town, Eastern Zone, Tigray Region, Ethiopia”

 

 

Dr. Ji-Wei Ren | Organic Chemistry | Best Researcher Award

Posted on by Chemistry Awards

Dr. Ji-Wei Ren | Organic Chemistry | Best Researcher Award

Dr. Ji-Wei Ren, Organic Chemistry, Taishan University , China 

Dr. Ji-Wei Ren is a Lecturer in the College of Chemistry and Chemical Engineering at Taishan University, China. He earned his Ph.D. in Chemical Engineering and Technology from Central South University, where he developed expertise in visible light catalysis, organo catalysis, and green synthesis. Dr. Ren has previously served as a Research Associate at Ningbo University’s Institute of Drug Discovery Technology, engaging in interdisciplinary research on biomimetic reducing agents and chiral resolution. With a strong foundation in heterocyclic construction and peptide synthesis, his work integrates sustainable and biomimetic chemistry with modern synthetic methodologies. Dr. Ren has published multiple high-impact research articles in leading journals such as Org. Lett., J. Org. Chem., and Org. Chem. Front.. His research is characterized by innovation, precision, and relevance to both pharmaceutical and materials chemistry. He actively contributes to academic platforms like ORCID and collaborates with renowned scientists across China.

Professional Profile :         

Orcid

Scopus 

Summary of Suitability for Award:

Dr. Ji-Wei Ren exemplifies the qualities of an outstanding researcher through his pioneering work in the field of organic synthesis, particularly in visible light catalysis, organocatalysis, and green chemistry. He has published over 11 peer-reviewed articles in top-tier journals such as Organic Chemistry Frontiers, Journal of Organic Chemistry, Organic Letters, and Chemistry – A European Journal. Several of his works have been highlighted by Synfacts, showcasing their novelty and scientific impact. His innovative contributions include the development of racemization-free synthesis protocols, the application of biomimetic reducing agents, and the design of sustainable methodologies for heterocycle and peptide construction. He brings a fresh perspective to traditional synthetic methods by incorporating visible light and bio-inspired techniques, addressing both the efficiency and environmental responsibility in chemical synthesis. Dr. Ji-Wei Ren is highly suitable for the “Best Researcher Award”. His significant scientific output, innovation in research, recognition by the international community, and dedication to sustainable chemistry clearly distinguish him as a leading researcher in his field. His commitment to impactful and environmentally conscious science makes him not only an excellent candidate but also a role model for emerging researchers. This award would be a deserving recognition of his ongoing contributions to the scientific world.

🎓Education:

Dr. Ji-Wei Ren completed both his undergraduate and doctoral studies at Central South University. He earned his Bachelor of Engineering in Pharmaceutical Engineering in June 2013, where he gained foundational knowledge in pharmaceutical chemistry, drug design, and synthesis. Subsequently, he pursued a Doctorate in Chemical Engineering and Technology (2013–2019) at the same university. His Ph.D. research focused on innovative synthetic strategies using organo catalysis and visible-light-driven methodologies for the construction of functional molecules, especially in the development of peptide and heterocyclic compounds. Under the mentorship of distinguished faculty, he honed his skills in reaction design, stereoselective synthesis, and catalysis. His academic training also included a deep understanding of biomimetic reactions, green synthesis, and photochemical transformations. This robust educational background laid the groundwork for his interdisciplinary research efforts, enabling him to contribute significantly to the fields of sustainable and asymmetric synthesis.

🏢Work Experience:

Dr. Ji-Wei Ren began his academic career as a Research Associate (2019–2022) at the Institute of Drug Discovery Technology, Ningbo University, where he focused on peptide synthesis and the development of bio-inspired reducing agents. His role involved collaborative projects in pharmaceutical chemistry and catalysis, contributing to the advancement of efficient and eco-friendly synthetic methods. In August 2022, he joined Taishan University as a Lecturer in the College of Chemistry and Chemical Engineering. At Taishan University, Dr. Ren continues his research in visible light catalysis and organocatalytic transformations, guiding students in advanced organic chemistry techniques and experimental methodologies. He has also contributed to curriculum development and interdisciplinary research programs. His teaching and research philosophy is rooted in innovation, sustainability, and student engagement. With over a decade of academic training and research, Dr. Ren combines a strong theoretical foundation with hands-on experience in both industrial and academic labs.

🏅Awards: 

Dr. Ji-Wei Ren has been consistently recognized for his impactful contributions to organic chemistry and green synthesis methodologies. His 2021 publication in Organic Letters was highlighted by Synfacts in 2022 for its innovative racemization-free synthesis approach, underlining the originality and practical importance of his work. Additionally, his earlier work in The Journal of Organic Chemistry (2017) was also spotlighted in Synfacts, reflecting his ongoing excellence in visible light-mediated and organocatalytic transformations. During his doctoral studies at Central South University, he was honored with multiple academic excellence awards for his outstanding research and scholarly dedication. His publications in top-tier journals like Organic Chemistry Frontiers, Organic & Biomolecular Chemistry, and Chemistry – A European Journal have further established him as a rising expert in his field. These recognitions underscore both the scientific value and the practical applicability of his research in modern organic synthesis.

🔬Research Focus:

Dr. Ji-Wei Ren’s research is centered on the development of innovative, environmentally friendly methodologies in organic synthesis. His primary interests lie in visible light catalysis, where he designs photochemical processes to enable mild and selective transformations. He is also deeply involved in chiral resolution and organocatalysis, with a particular emphasis on enantioselective reactions that are crucial for pharmaceutical synthesis. A significant part of his work involves constructing complex heterocyclic compounds, often using biomimetic and green synthesis strategies to reduce environmental impact. Dr. Ren has pioneered the use of L-amino acid esters as biomimetic reducing agents and introduced new deoxygenation and amidation protocols that avoid racemization—critical for peptide and amide bond formation. His interdisciplinary approach blends traditional organic chemistry with sustainability, aiming to create scalable, efficient, and selective processes suitable for industrial application. His contributions significantly enhance both academic understanding and practical implementation in organic synthesis.

Publication Top Notes:

“A visible light-mediated deoxygenation protocol for the synthesis of dipeptides, amides and esters without racemization”​

“L-Amino acid ester as a biomimetic reducing agent for the reduction of unsaturated C=C bonds”

“Umpolung Strategy for the One-Pot Synthesis of Highly Steric Bispirooxindoles via the L-Amino Acid Ester-Promoted In Situ Reduction/Nucleophilic Addition/Cyclization Cascade Reaction”​

“A visible light-induced deoxygenative amidation protocol for the synthesis of dipeptides and amides”​

“An organocatalytic enantioselective ring-reorganization domino sequence of methyleneindolinones with 2-aminomalonates”​

“Straightforward Synthesis of 3-Selenocyanato-Substituted Chromones through Electrophilic Selenocyanation of Enaminones under Grinding Conditions”​

“Organocatalytic, Enantioselective, Polarity-Matched Ring-Reorganization Domino Sequence Based on the 3-Oxindole Scaffold”

“A One‐Pot Ring‐Opening/Ring‐Closure Sequence for the Synthesis of Polycyclic Spirooxindoles”​

“L-Pyroglutamic Sulphonamide as Hydrogen-Bonding Organocatalyst: Enantioselective Diels–Alder Cyclization to Construct Carbazolespirooxindoles”

“Acid-Relayed Organocatalytic exo-Diels-Alder Cycloaddition of Cyclic Enones with 2-Vinyl-1H-indoles”

 

Prof. Mohammad Bakherad | Organic Chemistry | Best Researcher Award

Posted on by Chemistry Awards

Prof. Mohammad Bakherad | Organic Chemistry | Best Researcher Award

Prof. Mohammad Bakherad | Organic Chemistry | Researcher at Shahrood University of Technology, Iran

Mohammad Bakherad, born in 1969 in Mashhad, Iran, is a distinguished Professor of Organic Chemistry at Shahrood University of Technology. He earned his B.Sc. in Chemistry from Isfahan University (1992) and completed his M.Sc. (1995) and Ph.D. (2002) at Ferdowsi University of Mashhad under the mentorship of Majid M. Heravi and Mohammad Rahimizadeh. With a prolific research career, he has published over 147 ISI-indexed papers, contributing significantly to organic synthesis, heterocyclic chemistry, catalysis, and green chemistry. His expertise in organometallic reagents and innovative synthetic methodologies has gained international recognition. He has mentored numerous students and led cutting-edge research projects. His commitment to academic excellence and scientific contributions continues to shape the field of organic chemistry in Iran and beyond.

Professional Profile :         

Scopus 

Summary of Suitability for Award:

Dr. Mohammad Bakherad is a highly accomplished researcher in the field of organic chemistry, particularly in catalysis, heterocyclic chemistry, and green synthetic methodologies. His academic journey, from earning a Ph.D. in Organic Chemistry at Ferdowsi University of Mashhad to becoming a full Professor at Shahrood University of Technology, demonstrates his dedication to research and innovation. With over 147 ISI-cited papers, his contributions have significantly advanced the understanding and application of novel catalytic and environmentally friendly synthetic approaches. Dr. Mohammad Bakherad’s outstanding publication record, pioneering research in organic synthesis and catalysis, and commitment to sustainable chemistry make him an exceptional candidate for the “Best Researcher Award.” His work has had a profound impact on the scientific community, shaping the future of organic chemistry. His innovative methodologies, leadership in academia, and dedication to mentorship and collaborative research make him highly deserving of this recognition.

🎓Education:

Mohammad Bakherad pursued his B.Sc. in Chemistry at Isfahan University, Iran, from 1988 to 1992. He then continued his academic journey at Ferdowsi University of Mashhad, where he obtained his M.Sc. in Organic Chemistry (1993–1996) and later earned his Ph.D. in Organic Chemistry (1996–2002). His doctoral research was conducted under the supervision of esteemed professors Majid M. Heravi and Mohammad Rahimizadeh, focusing on advanced organic synthesis and heterocyclic chemistry. His academic background provided him with a strong foundation in organic methodologies, catalysis, and the development of novel heterocyclic compounds. Through rigorous training and research, he developed expertise in the synthesis of organic frameworks, organometallic reagents, and green chemistry applications. His educational journey laid the groundwork for a prolific career in organic synthesis, contributing significantly to the field with numerous publications and advancements in catalytic and environmentally friendly synthetic approaches.

🏢Work Experience:

Dr. Mohammad Bakherad has had an extensive academic career, beginning as an Assistant Professor of Organic Chemistry at Shahrood University of Technology in July 2003. His dedication and contributions to research and teaching led to his promotion to Associate Professor in January 2008. In February 2013, he achieved the rank of Professor, solidifying his position as a leading researcher in organic and heterocyclic chemistry. Throughout his career, he has mentored numerous students, guiding them in advanced research methodologies and fostering innovation in catalysis and organic synthesis. His teaching experience spans undergraduate and postgraduate levels, covering specialized topics such as organometallic chemistry, synthetic methodologies, and green chemistry. Additionally, he has been actively involved in collaborative research projects, contributing to cutting-edge developments in organic chemistry. His expertise has led to significant advancements in sustainable chemical processes and the development of novel heterocyclic frameworks.

🏅Awards: 

Dr. Mohammad Bakherad has received numerous accolades in recognition of his outstanding contributions to organic chemistry. He has been honored for his pioneering work in catalysis, green synthetic methods, and heterocyclic chemistry. His research excellence has been acknowledged through multiple awards from national and international scientific organizations. He has been invited as a keynote speaker at prestigious conferences, highlighting his expertise in organic synthesis and catalytic methodologies. His scholarly achievements include being recognized for his high-impact publications in leading scientific journals. Furthermore, his commitment to mentorship and academic excellence has earned him appreciation from students and colleagues alike. As a distinguished researcher, he has also been part of various scientific committees, contributing to the advancement of chemistry education and research. His contributions continue to shape the field, fostering innovation and inspiring future generations of chemists.

🔬Research Focus:

Dr. Mohammad Bakherad’s research focuses on organic synthesis, particularly in heterocyclic chemistry, catalysis, and green synthetic methodologies. He has made significant contributions to the development of novel heterocyclic compounds and organometallic reagents, which play a crucial role in medicinal and materials chemistry. His work in catalytic processes has led to innovative and environmentally friendly approaches for synthesizing complex organic molecules. He has explored palladium-catalyzed reactions, Sonogashira coupling, and cyclocondensation techniques to design efficient synthetic routes. Additionally, his interest in sustainable chemistry has driven his research on recyclable catalysts and water-based reactions, reducing the environmental impact of chemical synthesis. His extensive studies on heteroannulation reactions have resulted in the creation of novel bioactive molecules with potential pharmaceutical applications. With over 147 ISI-cited papers, his research continues to influence advancements in organic and green chemistry, making a lasting impact on the scientific community.

Publication Top Notes:

Synthesis, QSAR modeling, and molecular docking studies of 1,2,3-triazole-pyrazole hybrids as significant anti-cancer and anti-microbial agents

Synthesis of new hybrid compounds of imidazo[1,2-a]pyrimidine/pyridine based on quinoxaline through palladium-catalyzed coupling reactions and heteroannulation

A comprehensive review: medicinal applications and diverse synthetic strategies of pyrimidine-based compounds leveraging Suzuki and Sonogashira reactions

Synthesis, and molecular docking studies of novel 1,2,3-triazoles-linked pyrazole carboxamides as significant anti-microbial and anti-cancer agents

Copper catalysts supported by dehydroacetic acid chitosan schiff base for CuAAC click reaction in water

Citations: 1

Furo, Pyrano, and Pyrido[2,3-d]Pyrimidines: A Comprehensive Review of Synthesis and Medicinal Applications

Citations: 5

Synthesis of new 1,2,3-triazole-linked pyrimidines by click reaction

Synthesis of new 4,5-disubstituted-6-methyl-2-(methylthio) pyrimidines via C-C coupling reactions

New Hybrid Compounds from Imidazole and 1,2,3-Triazole: Efficient Synthesis of Highly Substituted Imidazoles and Construction of Their Novel Hybrid Compounds by Copper-Catalyzed Click Reaction

Citations: 1

An Efficient Synthesis of New Pyrazole-Linked Oxazoles via Sonogashira Coupling Reaction

Citations: 2

Prof. Dr. Pengwei Zhao | Medicinal Chemistry | Best Researcher Award

Posted on by Chemistry Awards

Prof. Dr. Pengwei Zhao | Medicinal Chemistry | Best Researcher Award

Prof. Dr. Pengwei Zhao | Medicinal Chemistry | Ph.D., Master’s Supervisor at Inner Mongolia Medical University, School of Basic Medical Sciences, China 

Dr. Pengwei Zhao is a Professor at the School of Basic Medical Sciences, Inner Mongolia Medical University, he serves as a master’s supervisor and holds various academic positions. He is a member of the Jiusan Society and actively contributes to scientific research as a registered reviewer for Medical Science Monitor and Chinese Journal of Tissue Engineering Research. He is also a youth editorial board member of Modern Oncology and a director of the Inner Mongolia Bioengineering Society. His research focuses on tumor immunology and pharmacological mechanisms of Mongolian medicine. Dr. Zhao has led multiple national and regional research projects, including studies on β-defensins, immune resistance, and cancer treatment mechanisms. His contributions to microbiology and oncology are widely recognized, with several impactful publications in international journals.

Professional Profile : 

Orcid

Scopus 

Summary of Suitability for Award:

Dr. Pengwei Zhao, a distinguished Professor at Inner Mongolia Medical University, has made significant contributions to tumor immunology, cancer pharmacology, and Mongolian medicine. His research on β-defensins and their role in immune modulation and cancer therapy has led to groundbreaking findings, particularly in colorectal and triple-negative breast cancer (TNBC). With numerous high-impact publications, including in Pharmacogenomics Journal and World Journal of Gastrointestinal Oncology, his work is recognized globally. His ongoing National Natural Science Foundation of China project further highlights his leadership in cancer research.  Dr. Pengwei Zhao’s extensive research, innovative methodologies, and interdisciplinary approach make him an outstanding candidate for the “Best Researcher Award”. His contributions to immunotherapy, autophagy, and microbiome-related cancer treatments have the potential to shape future oncological therapies. Recognizing him with this award would honor his pioneering discoveries and impact on global cancer research.

🎓Education:

Dr. Pengwei Zhao holds a Ph.D. in Basic Medical Sciences with a specialization in tumor immunology and pharmacology. His doctoral research focused on β-defensin-mediated immune modulation and cancer therapy. He pursued his higher education at Inner Mongolia Medical University, where he developed expertise in molecular biology, pharmacology, and immunology. His early education emphasized microbiology and traditional Mongolian medicine. Dr. Zhao further enhanced his skills through postdoctoral research and collaborations with leading scientists in cancer biology. His education provided a strong foundation in oncological pharmacology, signaling pathways, and immune resistance mechanisms. He has continuously expanded his knowledge through national and international conferences, workshops, and training programs. His academic journey reflects a commitment to translational research, bridging basic science with clinical applications in cancer therapy.

🏢Work Experience:

Dr. Zhao has been a Professor at Inner Mongolia Medical University for several years, where he also serves as a Master’s Supervisor. His professional roles extend beyond teaching, as he holds multiple directorial positions in national and regional scientific societies. He is a reviewer for prestigious journals, including Medical Science Monitor and Chinese Journal of Digestive Diseases. As a youth editorial board member of Modern Oncology, he actively contributes to cancer research. He has successfully led multiple research projects funded by national and regional agencies, focusing on cancer immunology, microbiology, and Mongolian medicine-based therapies. Additionally, Dr. Zhao has conducted collaborative research on β-defensins, autophagy, and immune resistance mechanisms. His expertise in pharmacological pathways and microbial interactions has significantly advanced the understanding of cancer treatment. He has also been invited as a speaker and panelist at various oncology and pharmacology conferences.

🏅Awards: 

Dr. Pengwei Zhao has received multiple prestigious awards and honors in recognition of his contributions to tumor immunology and Mongolian medicine research. He has been honored by the Inner Mongolia Medical University for excellence in research and mentorship. His work on β-defensins and their role in cancer has earned him accolades from Inner Mongolia’s Science and Technology Department. He has also received distinguished reviewer awards from journals such as Medical Science Monitor and Chinese Journal of Tissue Engineering Research. As a key member of the Chinese Society of Ethnomedicine and Pharmacy, he has been acknowledged for his research on the pharmacological mechanisms of traditional Mongolian medicine. His contributions to microbiology and immunology have been recognized by the Inner Mongolia Microbiology Society, and he has been invited as a young committee member of the Chinese Microbiological Society’s Clinical Microbiology Professional Committee.

🔬Research Focus:

Dr. Pengwei Zhao’s research primarily focuses on tumor immunology, cancer pharmacology, and the therapeutic potential of Mongolian medicine. He investigates the molecular mechanisms of β-defensins in cancer, particularly their role in immune regulation and tumor suppression. His work explores how β-defensin-1 peptides modulate PD-1/PD-L1 immune resistance in colorectal cancer. Additionally, he studies Mongolian medicinal formulations like Sendeng-4 and their mechanisms against skin cancer. His research also extends to microbiology, analyzing how bacterial infections, such as those caused by Staphylococcus aureus and Klebsiella pneumoniae, influence lung epithelial immune responses. Dr. Zhao has also contributed significantly to understanding long noncoding RNAs (lncRNAs) and their regulatory impact on autophagy pathways in cancer. His interdisciplinary approach integrates immunology, molecular biology, and ethnopharmacology, providing novel insights into cancer therapy, host-pathogen interactions, and the development of targeted immunotherapies.

Publication Top Notes:

Upregulation of p300 in paclitaxel-resistant TNBC: implications for cell proliferation via the PCK1/AMPK axis

Authors: P. Zhao, Pengwei; J. Cui, Jiaxian; X. Wang, Xiumei

Journal: Pharmacogenomics Journal

Year: 2024

Citations: 2

Human β-defensin-1 affects the mammalian target of rapamycin pathway and autophagy in colon cancer cells through long non-coding RNA TCONS_00014506

Authors: Y. Zhao, Yuxin; Y. Cui, Yan; X. Li, Xinhong; L. Bao, Lili; P. Zhao, Pengwei

Journal: World Journal of Gastrointestinal Oncology

Year: 2024

Citations: 3

Effect of Staphylococcus aureus in pneumonia mouse model on promotion of mBD-3 expression through ERK1/2

Authors: Yongqing Ni, Xiaoduo Bi, Pengwei Zhao

Ligilactobacillus salivarius LZZAY01 accelerated autophagy and apoptosis in colon cancer cells and improved gut microbiota in CAC mice

Authors: Yang W, Li T, An S, Chen R, Zhao Y, Cui J, Zhang M, Lu J, Tian Y, Bao L, Zhao P

Journal: Microbiol Spectrum

Year: 2025

LPS Promoted HPMEC Autophagy by Suppression of the PI3K/Akt/mTOR through Inhibited TIMAP-Promoted Moesin Expression in Sepsis

Authors: Jili Wen, Pengwei Zhao, HuiJuan Ren, JunMin Wu

Journal: Journal of Biological Regulators and Homeostatic Agents

Year: 2023

 

Khalid Khan | Organic Chemistry | Best Researcher Award

Posted on by Chemistry Awards

Assoc Prof Dr. Khalid Khan | Organic Chemistry | Best Researcher Award

Associate Professor at Islamia College University, Peshawar, Pakistan

Dr. Khalid Khan is an accomplished chemist with extensive expertise in organic chemistry and medicinal research. He obtained his PhD from Huazhong University of Science and Technology in China, focusing on the design and synthesis of novel dendro-calix[4]arenes. Currently, he serves as an Associate Professor at Islamia College University in Peshawar, Pakistan, where he leads various research projects and supervises graduate and undergraduate students. His work has significantly contributed to the field of drug discovery, particularly in computational and medicinal chemistry.

Author Metrics

Scopus Profile

Dr. Khan has published over 25 research articles in reputable journals, showcasing his research impact and contribution to the field of chemistry. His work has garnered numerous citations, reflecting the relevance and influence of his research on both national and international platforms. His publication metrics highlight his active engagement in advancing scientific knowledge, particularly in the areas of antiviral drug development and nanotechnology.

  • Citations: 414 citations across 379 documents
  • Documents: 21 published works
  • h-index: 9

Education

Dr. Khan completed his PhD in Chemistry from Huazhong University of Science and Technology, China (2008-2013), where he conducted groundbreaking research on nonionic amphiphilic dendro-calix[4]arenes. He holds a Master’s degree in Chemistry from the University of Peshawar (2002-2004), where he graduated with first-class honors, and a Bachelor’s degree in Biological Science from Government College Peshawar (2000-2002).

Research Focus

Dr. Khan’s research primarily revolves around organic chemistry, with a special focus on the synthesis and characterization of bioactive compounds. He is particularly interested in the development of antiviral agents and the computational modeling of drug interactions with viral proteins. His innovative research projects often explore the structure-activity relationships of compounds to enhance therapeutic efficacy.

Professional Journey

Beginning his career as a lecturer in 2005, Dr. Khan progressively advanced to the role of Associate Professor in 2020 at Islamia College University. Throughout his tenure, he has significantly contributed to the academic environment by designing curricula, supervising research, and engaging in community service. His professional journey is marked by a commitment to education, research, and the development of future scientists.

Honors & Awards

Dr. Khan has received several prestigious awards, including the Pakistan and Chinese Government Cultural Exchange Scholarship for his doctoral studies. He was recognized as the topper in his Master’s program, reflecting his dedication and excellence in the field of chemistry. His achievements have earned him a respected place among his peers in academia.

Publications Noted & Contributions

Among his numerous publications, key works include research on the design and synthesis of novel dendro-calix[4]arenes, antiviral drug development, and the characterization of compounds with potential therapeutic applications. His contributions have advanced understanding in various areas of organic chemistry and nanotechnology, facilitating further research in these domains.

Homology modeling and molecular docking study of metabotropic glutamate receptor 5 variant F: An attempt to develop drugs for treating CNS diseases

  • Authors: Ahmad, N., Khan, K., Rashid, H.U., Ullah, R., Ali, E.A.
  • Journal: Zeitschrift für Physikalische Chemie
  • Year: 2024
  • Volume: 238, Issue 8, Pages 1551–1577
  • Citations: 1

Direct synthesis, characterization, in vitro and in silico studies of simple chalcones as potential antimicrobial and antileishmanial agents

  • Authors: Ur Rashid, H., Khan, S., Irum, Shah, T., Khan, K.
  • Journal: Royal Society Open Science
  • Year: 2024
  • Volume: 11, Article 240410
  • Citations: 0

Homology modeling and molecular docking study of corticotrophin-releasing hormone: An approach to treat stress-related diseases

  • Authors: Ahmad, N., Khan, K., Khan, S.W., Ullah, R., Ali, E.A.
  • Journal: Open Chemistry
  • Year: 2024
  • Volume: 22, Article 20240069
  • Citations: 0

Biological investigations of Aspergillus ficuum via in vivo, in vitro and in silico analyses

  • Authors: Shah, Z.A., Khan, K., Shah, T., Muhammad, A., Rashid, H.
  • Journal: Scientific Reports
  • Year: 2023
  • Volume: 13, Article 17260
  • Citations: 1

Insights into metabolic and pharmacological profiling of Aspergillus ficuum through bioinformatics and experimental techniques

  • Authors: Shah, Z.A., Khan, K., Rashid, H.U., Jaremko, M., Iqbal, Z.
  • Journal: BMC Microbiology
  • Year: 2022
  • Volume: 22, Article 295
  • Citations: 4

Research Timeline

Dr. Khan’s research trajectory spans over a decade, beginning with his PhD studies from 2008 to 2013, followed by various research projects involving computational analyses and synthesis of organic compounds. His ongoing projects encompass a wide range of studies aimed at understanding and inhibiting viral proteins, particularly related to SARS-CoV-2 and other pathogenic viruses.

Collaborations and Projects

Dr. Khan has collaborated with both national and international researchers on diverse projects, enhancing the scope and impact of his research. These collaborations have resulted in joint publications and a collective effort to address significant challenges in medicinal chemistry and virology. His ability to work across disciplines and institutions underscores his commitment to collaborative scientific inquiry.

Conclusion

Dr. Khalid Khan’s recognition as a Best Researcher reflects his significant contributions to organic chemistry and medicinal research. His publication record and collaborative efforts enhance his impact within the scientific community. By addressing areas for improvement, such as increasing citation metrics and expanding research diversification, Dr. Khan can further strengthen his position as a leader in his field. His commitment to education and research not only benefits his students but also contributes to the broader scientific landscape, making his work essential for advancements in drug discovery and public health.